Myocardial ketone body oxidation underlies the salutary effects of SGLT2 inhibitor treatment in heart failure
S. N. Voorrips,H. Saucedo-Orozco,B. Mahmoud,E. M. Schouten,K. T. Nijholt,C. L. Palm,T. R. Matsuura,S. R. Yurista,P. Van der Meer,R. A. De Boer,H. H. W. Sillje,D. P. Kelly,B. D. Westenbrink
